U.S. flag

An official website of the United States government

NM_000055.4(BCHE):c.100del (p.Ile34fs) AND Deficiency of butyrylcholinesterase

Germline classification:
Pathogenic/Likely pathogenic (2 submissions)
Last evaluated:
Nov 1, 2021
Review status:
2 stars out of maximum of 4 stars
criteria provided, multiple submitters, no conflicts
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV001784360.5

Allele description [Variation Report for NM_000055.4(BCHE):c.100del (p.Ile34fs)]

NM_000055.4(BCHE):c.100del (p.Ile34fs)

Gene:
BCHE:butyrylcholinesterase [Gene - OMIM - HGNC]
Variant type:
Deletion
Cytogenetic location:
3q26.1
Genomic location:
Preferred name:
NM_000055.4(BCHE):c.100del (p.Ile34fs)
HGVS:
  • NC_000003.12:g.165830935del
  • NG_009031.1:g.11532del
  • NM_000055.4:c.100delMANE SELECT
  • NP_000046.1:p.Ile34fs
  • NC_000003.11:g.165548723del
  • NR_137636.2:n.218del
Protein change:
I34fs
Links:
dbSNP: rs750309713
NCBI 1000 Genomes Browser:
rs750309713
Molecular consequence:
  • NM_000055.4:c.100del - frameshift variant - [Sequence Ontology: SO:0001589]
  • NR_137636.2:n.218del - non-coding transcript variant - [Sequence Ontology: SO:0001619]

Condition(s)

Name:
Deficiency of butyrylcholinesterase (BCHED)
Synonyms:
Butyrylcholinesterase deficiency; BCHE deficiency; CHE1 deficiency; See all synonyms [MedGen]
Identifiers:
MONDO: MONDO:0015270; MedGen: C1283400; OMIM: 617936

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV002022029Revvity Omics, Revvity
criteria provided, single submitter

(ACMG Guidelines, 2015)
Likely pathogenic
(Nov 1, 2021)
germlineclinical testing

PubMed (1)
[See all records that cite this PMID]

SCV002787422Fulgent Genetics, Fulgent Genetics
criteria provided, single submitter

(ACMG Guidelines, 2015)
Pathogenic
(Oct 4, 2021)
unknownclinical testing

PubMed (1)
[See all records that cite this PMID]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedunknownunknownnot providednot providednot providednot providednot providedclinical testing
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology.

Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, Grody WW, Hegde M, Lyon E, Spector E, Voelkerding K, Rehm HL; ACMG Laboratory Quality Assurance Committee..

Genet Med. 2015 May;17(5):405-24. doi: 10.1038/gim.2015.30. Epub 2015 Mar 5.

PubMed [citation]
PMID:
25741868
PMCID:
PMC4544753

Details of each submission

From Revvity Omics, Revvity, SCV002022029.3

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (1)
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

From Fulgent Genetics, Fulgent Genetics, SCV002787422.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (1)
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1unknownunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Mar 16, 2024